Cervical Cancer: Still a Major Global Burden Cervical cancer (CC) remains a serious global health issue, especially in low- and middle-income countries. Despite being largely preventable through HPV vaccination and screening, CC continues to affect […]
Could CRELD2 Be a Key Biomarker in Triple-Negative Breast Cancer? A new study from researchers at Necmettin Erbakan University suggests that a specific protein, CRELD2, might help predict outcomes for patients with triple-negative breast cancer […]
The peer review process is essential to maintaining the quality and reliability of scientific publications. Every month, the BiomolBiomed Editorial team recognizes a reviewer who has provided exceptional evaluations of the manuscripts they have reviewed. […]
Lung cancer is the leading cause of cancer-related deaths globally, with nearly 2.5 million new cases annually. Non-small cell lung cancer (NSCLC) accounts for approximately 80%–85% of all lung cancer cases. Most patients are diagnosed […]
The human body is an intricate network of systems, and central to its operation is the central nervous system (CNS), consisting of the brain and spinal cord—serving as the main command center. Understanding the CNS […]
Acute myeloid leukemia is a malignancy of blood cells, and it is known as the most common type of leukemia in adults. Even after the successful treatment, the majority of patients’ health deteriorates after a […]
Neonatal brain injury (NBI) is attracting considerable interest due to the lack of an effective prognostic model in clinical practice. Previous research has shown that serum glial fibrillary acidic protein (GFAP) might be a promising […]
Researches indicated that gastric cancer is the fifth most prevalent cancer globally and has the third-highest mortality rate among all cancers. Thus, it is imperative to explore biomarkers to assess patients’ prognoses and provide possible […]
Hepatocellular carcinoma (HCC) is a highly malignant tumor. Previous studies have shown that lots of genes are involved in the development of HCC and may be used as prognostic biomarkers of HCC. However, there are […]
Background The research on the molecular pathology of pancreatic cancer (PCC) has not been in-depth enough, and there is a lack of comprehensive analysis of the transcriptomics and clinical characteristics of the disease to determine […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH